Header cover image

Investing Ideas
/
Australian Pharmaceuticals & Biotech High Growth Potential Companies

Australian Pharmaceuticals & Biotech High Growth Potential Companies

Results

16

0 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

16 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	ACR Acrux	AU$0.045	2.3%	4.7%	AU$13.1m	AU$0.19	PS2.6x	E91.6%	0%
	BOT Botanix Pharmaceuticals	AU$0.32	0%	106.5%	AU$581.6m	AU$0.65	PS281x	E99.4%	n/a
	GSS Genetic Signatures	AU$0.70	1.4%	41.4%	AU$158.8m	AU$1.10	PS11.5x	E98.6%	n/a
	TLX Telix Pharmaceuticals	AU$22.58	-1.4%	141.0%	AU$7.6b	AU$25.62	PE153.6x	E38.3%	n/a
	CUV Clinuvel Pharmaceuticals	AU$13.04	-1.8%	-23.3%	AU$651.3m	AU$28.29	PE18.3x	E26.2%	0.4%
	OPT Opthea	AU$0.60	-7.6%	51.2%	AU$744.8m	AU$0.91	PS1848.4x	E61.9%	n/a
	ARX Aroa Biosurgery	AU$0.66	4.0%	-2.2%	AU$225.9m	AU$0.93	PS3.6x	E56.3%	n/a
	PER Percheron Therapeutics	AU$0.074	-6.3%	23.3%	AU$78.4m	AU$0.21	PS26.4x	E19.8%	n/a
	BDX BCAL Diagnostics	AU$0.10	0%	5.0%	AU$37.7m	AU$0.20	PS12.2x	E90.6%	n/a
	MSB Mesoblast	AU$1.51	-4.1%	290.9%	AU$1.7b	AU$1.46	PS189.1x	E61.5%	n/a
	LGP Little Green Pharma	AU$0.13	4.0%	8.3%	AU$39.2m	AU$0.17	PS1.5x	E110.1%	n/a
	MVP Medical Developments International	AU$0.42	-5.6%	-46.8%	AU$47.3m	AU$2.94	PS1.4x	E93.1%	0%
	MYX Mayne Pharma Group	AU$4.48	-8.4%	-7.6%	AU$363.5m	AU$6.09	PS0.9x	E110.0%	n/a
	EZZ EZZ Life Science Holdings	AU$2.61	-11.5%	321.0%	AU$115.9m	AU$5.45	PE16.6x	E17.9%	1.1%
	TRJ Trajan Group Holdings	AU$0.97	-13.7%	-22.0%	AU$148.5m	AU$1.40	PS1x	E99.2%	n/a
	CSL CSL	AU$276.47	-0.2%	7.1%	AU$133.9b	AU$327.80	PE32.9x	E13.0%	1.5%

Page 1 of 1